Design 制药
DSGN
10.31
-0.17
-1.62%
Design 制药
US · DSGN
#3479 按市值排名
上市于 2021
10.31
-0.17
-1.62%
实时 - 追踪5344个代码 - 心跳于507秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了1家。
- 机构持股总比例下降了1.0个百分点。
机构持股
- 机构持股比例
- 96.22% -1.01pp
- 机构数量
- 170 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund32.80%
Hedge Fund30.01%
VC/PE Fund18.12%
Individual/Insider14.08%
Private Company12.47%
Public Company2.25%
Government Pension Fund0.29%
Insurance Company0.16%
Family Office/Trust0.12%
主要股东 截至 2026-03-31
Aseem Ansari
12.25% · 7.67M 股
SR One Capital Management, LP
10.43% · 6.53M 股
Sirenia Capital Management LP
8.71% · 5.45M 股
Light Irrevocable Trusts
6.13% · 3.83M 股
Star Irrevocable Trust
6.13% · 3.83M 股
Quan Management LLC
5.41% · 3.38M 股
Logos Global Management, L.P.
4.79% · 3.00M 股
Baker Bros. Advisors LP
4.28% · 2.68M 股
Driehaus Capital Management LLC
4.25% · 2.66M 股
BlackRock
4.25% · 2.66M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪45份申报 · 37次买入 · 6次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Aseem Ansari | Co-Founder & Scientific Advisor | 12.25% |
| SR One Capital Management, LP | -- | 10.43% |
| Sean Jeffries | Chief Operating Officer | 1.31% |
| Rodney Lappe | Independent Director | 0.21% |
| Pratik Shah | Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson | 0.21% |
| John Schmid | Independent Director | 0.09% |
| Heather Berger | Independent Director | 0.00% |
| Justin Gover | Director | -- |
| David Shapiro | Independent Director | -- |
| Simeon George | Lead Independent Director | -- |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-06-08 | John Schmid | Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | Justin Gover | Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | David Shapiro | Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | Rodney Lappe | Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | Simeon George | Lead Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | Heather Berger | Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-03-30 | David Shapiro | Independent Director | Other Derivative Acquisition | +67,500 | $10.64 |
| 2026-01-01 | Pratik Shah | Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson | Other Derivative Acquisition | +750,000 | $9.10 |
| 2026-01-01 | Justin Gover | Director | Other Derivative Acquisition | +45,000 | $9.10 |
| 2026-01-01 | Chris Storgard | Chief Medical Officer | Other Derivative Acquisition | +250,000 | $9.10 |
| 2026-01-01 | Sean Jeffries | Chief Operating Officer | Other Derivative Acquisition | +375,000 | $9.10 |
| 2026-01-01 | Julie Burgess | Chief Accounting Officer | Other Derivative Acquisition | +150,000 | $9.10 |
| 2025-12-08 | Pratik Shah | Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson | Other Derivative Acquisition | +1,050,000 | $2.48 |
| 2025-11-17 | Logos Global Management, L.P. | -- | Intent to Sell (Form 144) | -120,000 | $7.43 |
| 2025-11-13 | Logos Global Management, L.P. | -- | Intent to Sell (Form 144) | -620,000 | $7.06 |
| 2025-11-06 | Logos Global Management, L.P. | -- | Intent to Sell (Form 144) | -415,000 | $6.87 |
| 2025-09-08 | Justin Gover | Director | Other Derivative Acquisition | +45,833 | $6.64 |
| 2025-08-12 | Logos Global Management, L.P. | -- | Open Market Disposition | -562,627 | $5.25 |
| 2025-06-09 | John Schmid | Independent Director | Other Derivative Acquisition | +19,000 | $4.01 |
| 2025-06-09 | Rodney Lappe | Independent Director | Other Derivative Acquisition | +19,000 | $4.01 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
Design 制药 讨论区 0 条评论